semaglutide cholecystitis S2653 The Role of GLP-1 Agonist in Acute... : American Journal of Gastroenterology Frontiers | Glucagon-like peptide-1 receptor

GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis

From a baseline mean body weight of 92.2 kg, the highest mean weight loss observed was 19.7%, about 17.5 kg, compared to 2.0%, about 1.6 kg, for placebo after 24 weeks of treatment

We know that obesity is associated with AF progression and worse outcomes- we've discussed that previously here

J Clin Endocrinol Metab (1987) 64(1):1904

Combine with a balanced, protein-forward diet to support GH/IGF-1 anabolic effects

Compare this to some injectable medications that include preservatives or stabilizers that commonly trigger reactions